These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22858285)

  • 1. Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis.
    Mehta NN; Li R; Krishnamoorthy P; Yu Y; Farver W; Rodrigues A; Raper A; Wilcox M; Baer A; DerOhannesian S; Wolfe M; Reilly MP; Rader DJ; VanVoorhees A; Gelfand JM
    Atherosclerosis; 2012 Sep; 224(1):218-21. PubMed ID: 22858285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cholesterol efflux capacity and atherogenic lipid profile in young women with PCOS.
    Roe A; Hillman J; Butts S; Smith M; Rader D; Playford M; Mehta NN; Dokras A
    J Clin Endocrinol Metab; 2014 May; 99(5):E841-7. PubMed ID: 24512495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile.
    Tom WL; Playford MP; Admani S; Natarajan B; Joshi AA; Eichenfield LF; Mehta NN
    J Invest Dermatol; 2016 Jan; 136(1):67-73. PubMed ID: 26763425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein concentration, particle number, size and cholesterol efflux capacity are associated with mitochondrial oxidative stress and function in an HIV positive cohort.
    Parikh NI; Gerschenson M; Bennett K; Gangcuangco LM; Lopez MS; Mehta NN; Playford MP; Nakamoto BK; Seto TB; Chow DC; Shikuma CM
    Atherosclerosis; 2015 Mar; 239(1):50-4. PubMed ID: 25574857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tofacitinib on lipid levels and lipid-related parameters in patients with moderate to severe psoriasis.
    Wolk R; Armstrong EJ; Hansen PR; Thiers B; Lan S; Tallman AM; Kaur M; Tatulych S
    J Clin Lipidol; 2017; 11(5):1243-1256. PubMed ID: 28751001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
    Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
    J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
    Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of lipid composition and high-density lipoprotein function in HIV-infected individuals on stable antiretroviral regimens.
    Munger AM; Chow DC; Playford MP; Parikh NI; Gangcuangco LM; Nakamoto BK; Kallianpur KJ; Ndhlovu LC; Shikuma CM; Mehta NN
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):221-8. PubMed ID: 25416403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.
    Sorokin AV; Kotani K; Elnabawi YA; Dey AK; Sajja AP; Yamada S; Ueda M; Harrington CL; Baumer Y; Rodante JA; Gelfand JM; Chen MY; Joshi AA; Playford MP; Remaley AT; Mehta NN
    Circ Res; 2018 Nov; 123(11):1244-1254. PubMed ID: 30571459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
    Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study.
    Yu Y; Sheth N; Krishnamoorthy P; Saboury B; Raper A; Baer A; Ochotony R; Doveikis J; Derohannessian S; Voorhees AS; Torigian DA; Alavi A; Gelfand JM; Mehta NN
    Am J Cardiovasc Dis; 2012; 2(4):285-92. PubMed ID: 23173102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial lipoprotein responses in hypertriglyceridemic subjects with and without cardiovascular disease.
    Hughes TA; Elam MB; Applegate WB; Bond MG; Hughes SM; Wang X; Tolley EA; Bittle JB; Stentz FB; Kang ES
    Metabolism; 1995 Aug; 44(8):1082-98. PubMed ID: 7637651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women.
    Mora S; Otvos JD; Rosenson RS; Pradhan A; Buring JE; Ridker PM
    Diabetes; 2010 May; 59(5):1153-60. PubMed ID: 20185808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability of non-high-density lipoprotein cholesterol and calculated intermediate-density lipoprotein to identify nontraditional lipoprotein subclass risk factors in dialysis patients.
    Belani SS; Goldberg AC; Coyne DW
    Am J Kidney Dis; 2004 Feb; 43(2):320-9. PubMed ID: 14750098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsoriatic treatment extends beyond the skin: recovering of high-density lipoprotein function.
    Marsche G; Holzer M; Wolf P
    Exp Dermatol; 2014 Oct; 23(10):701-4. PubMed ID: 24980461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.
    Mutharasan RK; Thaxton CS; Berry J; Daviglus ML; Yuan C; Sun J; Ayers C; Lloyd-Jones DM; Wilkins JT
    J Lipid Res; 2017 Mar; 58(3):600-606. PubMed ID: 28049656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR analysis of lipoprotein particle size does not increase sensitivity to the effect of soy protein on CVD risk when compared with the traditional lipid profile.
    Santo AS; Cunningham AM; Alhassan S; Browne RW; Burton H; Leddy JJ; Grandjean PW; Horvath SM; Horvath PJ
    Appl Physiol Nutr Metab; 2008 Jun; 33(3):489-500. PubMed ID: 18461102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.